CJ-13610, an orally active inhibitor of 5-lipoxygenase is efficacious in preclinical models of pain

Autor: Cortes-Burgos, Luz A., Zweifel, Ben S., Settle, Steven L., Pufahl, Robert A., Anderson, Gary D., Hardy, Medora M., Weir, Dana E., Hu, George, Happa, Fernando A., Stewart, Zachary, Muthian, Shanmugam, Graneto, Matthew J., Masferrer, Jaime L.
Zdroj: In European Journal of Pharmacology 2009 617(1):59-67
Databáze: ScienceDirect